98 related articles for article (PubMed ID: 25007848)
1. Antiviral effects of inhibiting host gene expression.
Tripp RA; Mark Tompkins S
Curr Top Microbiol Immunol; 2015; 386():459-77. PubMed ID: 25007848
[TBL] [Abstract][Full Text] [Related]
2. Screening methods for influenza antiviral drug discovery.
Atkins C; Evans CW; White EL; Noah JW
Expert Opin Drug Discov; 2012 May; 7(5):429-38. PubMed ID: 22435452
[TBL] [Abstract][Full Text] [Related]
3. Systematic review and meta-analysis of genome-wide pooled CRISPR screens to identify host factors involved in influenza A virus infection.
Maes A; Botzki A; Mathys J; Impens F; Saelens X
J Virol; 2024 May; 98(5):e0185723. PubMed ID: 38567969
[TBL] [Abstract][Full Text] [Related]
4. A small molecule multi-kinase inhibitor reduces influenza A virus replication by restricting viral RNA synthesis.
Martinez-Gil L; Alamares-Sapuay JG; Ramana Reddy MV; Goff PH; Premkumar Reddy E; Palese P
Antiviral Res; 2013 Oct; 100(1):29-37. PubMed ID: 23891991
[TBL] [Abstract][Full Text] [Related]
5. Repurposing host-based therapeutics to control coronavirus and influenza virus.
Li CC; Wang XJ; Wang HR
Drug Discov Today; 2019 Mar; 24(3):726-736. PubMed ID: 30711575
[TBL] [Abstract][Full Text] [Related]
6. Genetic screens for the control of influenza virus replication: from meta-analysis to drug discovery.
de Chassey B; Meyniel-Schicklin L; Aublin-Gex A; André P; Lotteau V
Mol Biosyst; 2012 Apr; 8(4):1297-303. PubMed ID: 22307679
[TBL] [Abstract][Full Text] [Related]
7. Systematic approaches towards the development of host-directed antiviral therapeutics.
Prussia A; Thepchatri P; Snyder JP; Plemper RK
Int J Mol Sci; 2011; 12(6):4027-52. PubMed ID: 21747723
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of influenza A virus replication by antagonism of a PI3K-AKT-mTOR pathway member identified by gene-trap insertional mutagenesis.
Murray JL; McDonald NJ; Sheng J; Shaw MW; Hodge TW; Rubin DH; O'Brien WA; Smee DF
Antivir Chem Chemother; 2012 May; 22(5):205-15. PubMed ID: 22374988
[TBL] [Abstract][Full Text] [Related]
9. Host gene targets for novel influenza therapies elucidated by high-throughput RNA interference screens.
Meliopoulos VA; Andersen LE; Birrer KF; Simpson KJ; Lowenthal JW; Bean AG; Stambas J; Stewart CR; Tompkins SM; van Beusechem VW; Fraser I; Mhlanga M; Barichievy S; Smith Q; Leake D; Karpilow J; Buck A; Jona G; Tripp RA
FASEB J; 2012 Apr; 26(4):1372-86. PubMed ID: 22247330
[TBL] [Abstract][Full Text] [Related]
10. Screening and identification of inhibitors against influenza A virus from a US drug collection of 1280 drugs.
An L; Liu R; Tang W; Wu JG; Chen X
Antiviral Res; 2014 Sep; 109():54-63. PubMed ID: 24971493
[TBL] [Abstract][Full Text] [Related]
11. Genome-wide RNAi screen for viral replication in mammalian cell culture.
Prusty BK; Karlas A; Meyer TF; Rudel T
Methods Mol Biol; 2011; 721():383-95. PubMed ID: 21431699
[TBL] [Abstract][Full Text] [Related]
12. A host susceptibility gene, DR1, facilitates influenza A virus replication by suppressing host innate immunity and enhancing viral RNA replication.
Hsu SF; Su WC; Jeng KS; Lai MM
J Virol; 2015 Apr; 89(7):3671-82. PubMed ID: 25589657
[TBL] [Abstract][Full Text] [Related]
13. Screening for host proteins with pro- and antiviral activity using high-throughput RNAi.
Griffiths SJ
Methods Mol Biol; 2013; 1064():71-90. PubMed ID: 23996250
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of influenza A virus replication by RNA interference targeted against the PB1 subunit of the RNA polymerase gene.
Li W; Yang X; Jiang Y; Wang B; Yang Y; Jiang Z; Li M
Arch Virol; 2011 Nov; 156(11):1979-87. PubMed ID: 21837415
[TBL] [Abstract][Full Text] [Related]
15. vhfRNAi: a web-platform for analysis of host genes involved in viral infections discovered by genome wide RNAi screens.
Thakur A; Qureshi A; Kumar M
Mol Biosyst; 2017 Jun; 13(7):1377-1387. PubMed ID: 28561835
[TBL] [Abstract][Full Text] [Related]
16. Identifying HIV-1 host cell factors by genome-scale RNAi screening.
Pache L; König R; Chanda SK
Methods; 2011 Jan; 53(1):3-12. PubMed ID: 20654720
[TBL] [Abstract][Full Text] [Related]
17. The promise, pitfalls and progress of RNA-interference-based antiviral therapy for respiratory viruses.
DeVincenzo JP
Antivir Ther; 2012; 17(1 Pt B):213-25. PubMed ID: 22311654
[TBL] [Abstract][Full Text] [Related]
18. Systems Biology-Based Investigation of Cellular Antiviral Drug Targets Identified by Gene-Trap Insertional Mutagenesis.
Cheng F; Murray JL; Zhao J; Sheng J; Zhao Z; Rubin DH
PLoS Comput Biol; 2016 Sep; 12(9):e1005074. PubMed ID: 27632082
[TBL] [Abstract][Full Text] [Related]
19. The combined use of alphavirus replicons and pseudoinfectious particles for the discovery of antivirals derived from natural products.
Delekta PC; Raveh A; Larsen MJ; Schultz PJ; Tamayo-Castillo G; Sherman DH; Miller DJ
J Biomol Screen; 2015 Jun; 20(5):673-80. PubMed ID: 25550354
[TBL] [Abstract][Full Text] [Related]
20. Endogenous antiviral microRNAs determine permissiveness for hepatitis B virus replication in cultured human fetal and adult hepatocytes.
Kumar M; Sharma Y; Bandi S; Gupta S
J Med Virol; 2015 Jul; 87(7):1168-83. PubMed ID: 25690916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
